JP2008520703A5 - - Google Patents

Download PDF

Info

Publication number
JP2008520703A5
JP2008520703A5 JP2007543267A JP2007543267A JP2008520703A5 JP 2008520703 A5 JP2008520703 A5 JP 2008520703A5 JP 2007543267 A JP2007543267 A JP 2007543267A JP 2007543267 A JP2007543267 A JP 2007543267A JP 2008520703 A5 JP2008520703 A5 JP 2008520703A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
formula
hydrogen
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007543267A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008520703A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/041817 external-priority patent/WO2006057899A2/en
Publication of JP2008520703A publication Critical patent/JP2008520703A/ja
Publication of JP2008520703A5 publication Critical patent/JP2008520703A5/ja
Ceased legal-status Critical Current

Links

JP2007543267A 2004-11-22 2005-11-18 ２α−メチル−１９−ノル−（２０Ｓ）−１α−ヒドロキシ−ビスホモプレグナカルシフェロールおよびその使用 Ceased JP2008520703A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63018404P 2004-11-22 2004-11-22
PCT/US2005/041817 WO2006057899A2 (en) 2004-11-22 2005-11-18 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses

Publications (2)

Publication Number Publication Date
JP2008520703A JP2008520703A (ja) 2008-06-19
JP2008520703A5 true JP2008520703A5 (enExample) 2009-01-15

Family

ID=36218156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007543267A Ceased JP2008520703A (ja) 2004-11-22 2005-11-18 ２α−メチル−１９−ノル−（２０Ｓ）−１α−ヒドロキシ−ビスホモプレグナカルシフェロールおよびその使用

Country Status (8)

Country Link
US (3) US7241751B2 (enExample)
EP (1) EP1846369A2 (enExample)
JP (1) JP2008520703A (enExample)
AU (1) AU2005309804B9 (enExample)
CA (1) CA2588399A1 (enExample)
MX (1) MX2007006542A (enExample)
NZ (1) NZ555283A (enExample)
WO (1) WO2006057899A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US7244719B2 (en) * 2004-11-22 2007-07-17 Wisconsin Alumni Research Foundation 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
AU2005309818A1 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20R)-1-alpha-hydroxy-bishomopregnacalciferol
NZ555283A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
ATE499942T1 (de) * 2004-11-22 2011-03-15 Wisconsin Alumni Res Found 2-methylen-19,21-dinor-1alpha-hydroxy- bishomopregnacalciferol
WO2006057884A2 (en) 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
US8399439B2 (en) * 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
US7879829B2 (en) * 2008-07-10 2011-02-01 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2-dihydrofuran ring
US7648974B1 (en) * 2008-07-10 2010-01-19 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US8217023B2 (en) 2009-10-02 2012-07-10 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
MX2012003883A (es) 2009-10-02 2012-06-27 Wisconsin Alumni Res Found Analogos de (20s,22e)-2-metileno-19-nor-22-ene-1a,25-dihidroxovita mina d3.
US8664206B2 (en) 2010-03-23 2014-03-04 Wisconsin Alumni Research Foundation Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
WO2011119610A2 (en) * 2010-03-23 2011-09-29 Wisconsin Alumni Research Foundation (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
JP5931845B2 (ja) * 2010-03-23 2016-06-08 ウイスコンシン アラムニ リサーチ ファンデーション ２−メチレン−１９−ノル−２２−メチル−１α，２５−ジヒドロキシビタミンＤ３のジアステレオマー
CN104086019A (zh) * 2014-06-17 2014-10-08 湖北富邦科技股份有限公司 一种工业高浓度含磷废水的处理方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
ES2309069T3 (es) * 2000-05-31 2008-12-16 Wisconsin Alumni Research Foundation Compuestos de 2-etil y 2-etiliden-19-nor-vitamina d.
BR0113703A (pt) * 2000-09-08 2003-07-22 Wisconsin Alumni Researcg Foun Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele
EP1392323B1 (en) * 2001-05-22 2008-10-08 Bioxell S.p.a. Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
GB0305332D0 (en) * 2003-03-10 2003-04-09 Leuven K U Res & Dev Biological evaluation of novel vitamin D analogues
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
CA2588412A1 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
WO2006057884A2 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES
NZ555283A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses

Similar Documents

Publication Publication Date Title
JP2008520689A5 (enExample)
JP2008520705A5 (enExample)
JP2008520691A5 (enExample)
JP2005529878A5 (enExample)
JP2010504995A5 (enExample)
CN103443085A (zh) 喹唑啉二酮及其应用
JP2006182786A5 (enExample)
CN101014329A (zh) 有效的医药使用方法及与副作用发生的防御相关的方法
JP2015508092A5 (enExample)
JP2008520704A5 (enExample)
JP2011521962A5 (enExample)
JP2008520716A5 (enExample)
CA2588415A1 (en) 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
JP2021105005A (ja) 癌治療
JP2008520709A5 (enExample)
JP2008520706A5 (enExample)
CA2588410A1 (en) 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
JP2010504994A5 (enExample)
JP2005502579A5 (enExample)
JP2008520708A5 (enExample)
Yue et al. Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents
TW420675B (en) N-substituted azaheterocyclic compounds
CA2531505A1 (en) (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
WO2019096095A1 (zh) 整合素受体靶向的抗癌偶联物
CA2588417A1 (en) 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses